Medical Care

Global Tumor Diagnosis Solutions Market Research Report 2025

The global market for Tumor Diagnosis Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Tumor Diagnosis Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Diagnosis Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor Diagnosis Solutions in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor Diagnosis Solutions include Dian Diagnostics Group, Sansure Biotech, YHLO Biotech, Thermo Fisher Scientific, Amoy Diagnostics, Ibex, Elephas, Philips Healthcare, Lepu Medical, Epredia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Diagnosis Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Diagnosis Solutions.
The Tumor Diagnosis Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Diagnosis Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Diagnosis Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dian Diagnostics Group
Sansure Biotech
YHLO Biotech
Thermo Fisher Scientific
Amoy Diagnostics
Ibex
Elephas
Philips Healthcare
Lepu Medical
Epredia
Roche
Caris Life Sciences
NeoGenomics
OncoDNA
Kheiron
Abbott
Mirada Medical
GuardantHealth
Labcorp
Segment by Type
Lung Cancer Diagnostic Services
Breast Cancer Diagnostic Services
Kidney Cancer Diagnostic Services
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Diagnosis Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Diagnosis Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lung Cancer Diagnostic Services
1.2.3 Breast Cancer Diagnostic Services
1.2.4 Kidney Cancer Diagnostic Services
1.2.5 Other
1.3 Market by Application
1.3.1 Global Tumor Diagnosis Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Diagnosis Solutions Market Perspective (2020-2031)
2.2 Global Tumor Diagnosis Solutions Growth Trends by Region
2.2.1 Global Tumor Diagnosis Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Diagnosis Solutions Historic Market Size by Region (2020-2025)
2.2.3 Tumor Diagnosis Solutions Forecasted Market Size by Region (2026-2031)
2.3 Tumor Diagnosis Solutions Market Dynamics
2.3.1 Tumor Diagnosis Solutions Industry Trends
2.3.2 Tumor Diagnosis Solutions Market Drivers
2.3.3 Tumor Diagnosis Solutions Market Challenges
2.3.4 Tumor Diagnosis Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Diagnosis Solutions Players by Revenue
3.1.1 Global Top Tumor Diagnosis Solutions Players by Revenue (2020-2025)
3.1.2 Global Tumor Diagnosis Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Diagnosis Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Diagnosis Solutions Revenue
3.4 Global Tumor Diagnosis Solutions Market Concentration Ratio
3.4.1 Global Tumor Diagnosis Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Diagnosis Solutions Revenue in 2024
3.5 Global Key Players of Tumor Diagnosis Solutions Head office and Area Served
3.6 Global Key Players of Tumor Diagnosis Solutions, Product and Application
3.7 Global Key Players of Tumor Diagnosis Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Diagnosis Solutions Breakdown Data by Type
4.1 Global Tumor Diagnosis Solutions Historic Market Size by Type (2020-2025)
4.2 Global Tumor Diagnosis Solutions Forecasted Market Size by Type (2026-2031)
5 Tumor Diagnosis Solutions Breakdown Data by Application
5.1 Global Tumor Diagnosis Solutions Historic Market Size by Application (2020-2025)
5.2 Global Tumor Diagnosis Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Diagnosis Solutions Market Size (2020-2031)
6.2 North America Tumor Diagnosis Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Diagnosis Solutions Market Size by Country (2020-2025)
6.4 North America Tumor Diagnosis Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Diagnosis Solutions Market Size (2020-2031)
7.2 Europe Tumor Diagnosis Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Diagnosis Solutions Market Size by Country (2020-2025)
7.4 Europe Tumor Diagnosis Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Diagnosis Solutions Market Size (2020-2031)
8.2 Asia-Pacific Tumor Diagnosis Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Diagnosis Solutions Market Size (2020-2031)
9.2 Latin America Tumor Diagnosis Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Diagnosis Solutions Market Size by Country (2020-2025)
9.4 Latin America Tumor Diagnosis Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Diagnosis Solutions Market Size (2020-2031)
10.2 Middle East & Africa Tumor Diagnosis Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dian Diagnostics Group
11.1.1 Dian Diagnostics Group Company Details
11.1.2 Dian Diagnostics Group Business Overview
11.1.3 Dian Diagnostics Group Tumor Diagnosis Solutions Introduction
11.1.4 Dian Diagnostics Group Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.1.5 Dian Diagnostics Group Recent Development
11.2 Sansure Biotech
11.2.1 Sansure Biotech Company Details
11.2.2 Sansure Biotech Business Overview
11.2.3 Sansure Biotech Tumor Diagnosis Solutions Introduction
11.2.4 Sansure Biotech Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.2.5 Sansure Biotech Recent Development
11.3 YHLO Biotech
11.3.1 YHLO Biotech Company Details
11.3.2 YHLO Biotech Business Overview
11.3.3 YHLO Biotech Tumor Diagnosis Solutions Introduction
11.3.4 YHLO Biotech Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.3.5 YHLO Biotech Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Tumor Diagnosis Solutions Introduction
11.4.4 Thermo Fisher Scientific Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Amoy Diagnostics
11.5.1 Amoy Diagnostics Company Details
11.5.2 Amoy Diagnostics Business Overview
11.5.3 Amoy Diagnostics Tumor Diagnosis Solutions Introduction
11.5.4 Amoy Diagnostics Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.5.5 Amoy Diagnostics Recent Development
11.6 Ibex
11.6.1 Ibex Company Details
11.6.2 Ibex Business Overview
11.6.3 Ibex Tumor Diagnosis Solutions Introduction
11.6.4 Ibex Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.6.5 Ibex Recent Development
11.7 Elephas
11.7.1 Elephas Company Details
11.7.2 Elephas Business Overview
11.7.3 Elephas Tumor Diagnosis Solutions Introduction
11.7.4 Elephas Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.7.5 Elephas Recent Development
11.8 Philips Healthcare
11.8.1 Philips Healthcare Company Details
11.8.2 Philips Healthcare Business Overview
11.8.3 Philips Healthcare Tumor Diagnosis Solutions Introduction
11.8.4 Philips Healthcare Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.8.5 Philips Healthcare Recent Development
11.9 Lepu Medical
11.9.1 Lepu Medical Company Details
11.9.2 Lepu Medical Business Overview
11.9.3 Lepu Medical Tumor Diagnosis Solutions Introduction
11.9.4 Lepu Medical Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.9.5 Lepu Medical Recent Development
11.10 Epredia
11.10.1 Epredia Company Details
11.10.2 Epredia Business Overview
11.10.3 Epredia Tumor Diagnosis Solutions Introduction
11.10.4 Epredia Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.10.5 Epredia Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Tumor Diagnosis Solutions Introduction
11.11.4 Roche Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.11.5 Roche Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Tumor Diagnosis Solutions Introduction
11.12.4 Caris Life Sciences Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.12.5 Caris Life Sciences Recent Development
11.13 NeoGenomics
11.13.1 NeoGenomics Company Details
11.13.2 NeoGenomics Business Overview
11.13.3 NeoGenomics Tumor Diagnosis Solutions Introduction
11.13.4 NeoGenomics Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.13.5 NeoGenomics Recent Development
11.14 OncoDNA
11.14.1 OncoDNA Company Details
11.14.2 OncoDNA Business Overview
11.14.3 OncoDNA Tumor Diagnosis Solutions Introduction
11.14.4 OncoDNA Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.14.5 OncoDNA Recent Development
11.15 Kheiron
11.15.1 Kheiron Company Details
11.15.2 Kheiron Business Overview
11.15.3 Kheiron Tumor Diagnosis Solutions Introduction
11.15.4 Kheiron Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.15.5 Kheiron Recent Development
11.16 Abbott
11.16.1 Abbott Company Details
11.16.2 Abbott Business Overview
11.16.3 Abbott Tumor Diagnosis Solutions Introduction
11.16.4 Abbott Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.16.5 Abbott Recent Development
11.17 Mirada Medical
11.17.1 Mirada Medical Company Details
11.17.2 Mirada Medical Business Overview
11.17.3 Mirada Medical Tumor Diagnosis Solutions Introduction
11.17.4 Mirada Medical Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.17.5 Mirada Medical Recent Development
11.18 GuardantHealth
11.18.1 GuardantHealth Company Details
11.18.2 GuardantHealth Business Overview
11.18.3 GuardantHealth Tumor Diagnosis Solutions Introduction
11.18.4 GuardantHealth Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.18.5 GuardantHealth Recent Development
11.19 Labcorp
11.19.1 Labcorp Company Details
11.19.2 Labcorp Business Overview
11.19.3 Labcorp Tumor Diagnosis Solutions Introduction
11.19.4 Labcorp Revenue in Tumor Diagnosis Solutions Business (2020-2025)
11.19.5 Labcorp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tumor Diagnosis Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Lung Cancer Diagnostic Services
Table 3. Key Players of Breast Cancer Diagnostic Services
Table 4. Key Players of Kidney Cancer Diagnostic Services
Table 5. Key Players of Other
Table 6. Global Tumor Diagnosis Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Tumor Diagnosis Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Tumor Diagnosis Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Tumor Diagnosis Solutions Market Share by Region (2020-2025)
Table 10. Global Tumor Diagnosis Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Tumor Diagnosis Solutions Market Share by Region (2026-2031)
Table 12. Tumor Diagnosis Solutions Market Trends
Table 13. Tumor Diagnosis Solutions Market Drivers
Table 14. Tumor Diagnosis Solutions Market Challenges
Table 15. Tumor Diagnosis Solutions Market Restraints
Table 16. Global Tumor Diagnosis Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Tumor Diagnosis Solutions Market Share by Players (2020-2025)
Table 18. Global Top Tumor Diagnosis Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Diagnosis Solutions as of 2024)
Table 19. Ranking of Global Top Tumor Diagnosis Solutions Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Tumor Diagnosis Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Tumor Diagnosis Solutions, Headquarters and Area Served
Table 22. Global Key Players of Tumor Diagnosis Solutions, Product and Application
Table 23. Global Key Players of Tumor Diagnosis Solutions, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tumor Diagnosis Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Tumor Diagnosis Solutions Revenue Market Share by Type (2020-2025)
Table 27. Global Tumor Diagnosis Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Tumor Diagnosis Solutions Revenue Market Share by Type (2026-2031)
Table 29. Global Tumor Diagnosis Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Tumor Diagnosis Solutions Revenue Market Share by Application (2020-2025)
Table 31. Global Tumor Diagnosis Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Tumor Diagnosis Solutions Revenue Market Share by Application (2026-2031)
Table 33. North America Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Tumor Diagnosis Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Tumor Diagnosis Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Tumor Diagnosis Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Tumor Diagnosis Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Tumor Diagnosis Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Tumor Diagnosis Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tumor Diagnosis Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 48. Dian Diagnostics Group Company Details
Table 49. Dian Diagnostics Group Business Overview
Table 50. Dian Diagnostics Group Tumor Diagnosis Solutions Product
Table 51. Dian Diagnostics Group Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 52. Dian Diagnostics Group Recent Development
Table 53. Sansure Biotech Company Details
Table 54. Sansure Biotech Business Overview
Table 55. Sansure Biotech Tumor Diagnosis Solutions Product
Table 56. Sansure Biotech Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 57. Sansure Biotech Recent Development
Table 58. YHLO Biotech Company Details
Table 59. YHLO Biotech Business Overview
Table 60. YHLO Biotech Tumor Diagnosis Solutions Product
Table 61. YHLO Biotech Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 62. YHLO Biotech Recent Development
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Tumor Diagnosis Solutions Product
Table 66. Thermo Fisher Scientific Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Amoy Diagnostics Company Details
Table 69. Amoy Diagnostics Business Overview
Table 70. Amoy Diagnostics Tumor Diagnosis Solutions Product
Table 71. Amoy Diagnostics Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 72. Amoy Diagnostics Recent Development
Table 73. Ibex Company Details
Table 74. Ibex Business Overview
Table 75. Ibex Tumor Diagnosis Solutions Product
Table 76. Ibex Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 77. Ibex Recent Development
Table 78. Elephas Company Details
Table 79. Elephas Business Overview
Table 80. Elephas Tumor Diagnosis Solutions Product
Table 81. Elephas Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 82. Elephas Recent Development
Table 83. Philips Healthcare Company Details
Table 84. Philips Healthcare Business Overview
Table 85. Philips Healthcare Tumor Diagnosis Solutions Product
Table 86. Philips Healthcare Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 87. Philips Healthcare Recent Development
Table 88. Lepu Medical Company Details
Table 89. Lepu Medical Business Overview
Table 90. Lepu Medical Tumor Diagnosis Solutions Product
Table 91. Lepu Medical Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 92. Lepu Medical Recent Development
Table 93. Epredia Company Details
Table 94. Epredia Business Overview
Table 95. Epredia Tumor Diagnosis Solutions Product
Table 96. Epredia Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 97. Epredia Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Tumor Diagnosis Solutions Product
Table 101. Roche Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 102. Roche Recent Development
Table 103. Caris Life Sciences Company Details
Table 104. Caris Life Sciences Business Overview
Table 105. Caris Life Sciences Tumor Diagnosis Solutions Product
Table 106. Caris Life Sciences Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 107. Caris Life Sciences Recent Development
Table 108. NeoGenomics Company Details
Table 109. NeoGenomics Business Overview
Table 110. NeoGenomics Tumor Diagnosis Solutions Product
Table 111. NeoGenomics Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 112. NeoGenomics Recent Development
Table 113. OncoDNA Company Details
Table 114. OncoDNA Business Overview
Table 115. OncoDNA Tumor Diagnosis Solutions Product
Table 116. OncoDNA Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 117. OncoDNA Recent Development
Table 118. Kheiron Company Details
Table 119. Kheiron Business Overview
Table 120. Kheiron Tumor Diagnosis Solutions Product
Table 121. Kheiron Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 122. Kheiron Recent Development
Table 123. Abbott Company Details
Table 124. Abbott Business Overview
Table 125. Abbott Tumor Diagnosis Solutions Product
Table 126. Abbott Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 127. Abbott Recent Development
Table 128. Mirada Medical Company Details
Table 129. Mirada Medical Business Overview
Table 130. Mirada Medical Tumor Diagnosis Solutions Product
Table 131. Mirada Medical Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 132. Mirada Medical Recent Development
Table 133. GuardantHealth Company Details
Table 134. GuardantHealth Business Overview
Table 135. GuardantHealth Tumor Diagnosis Solutions Product
Table 136. GuardantHealth Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 137. GuardantHealth Recent Development
Table 138. Labcorp Company Details
Table 139. Labcorp Business Overview
Table 140. Labcorp Tumor Diagnosis Solutions Product
Table 141. Labcorp Revenue in Tumor Diagnosis Solutions Business (2020-2025) & (US$ Million)
Table 142. Labcorp Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Tumor Diagnosis Solutions Picture
Figure 2. Global Tumor Diagnosis Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Diagnosis Solutions Market Share by Type: 2024 VS 2031
Figure 4. Lung Cancer Diagnostic Services Features
Figure 5. Breast Cancer Diagnostic Services Features
Figure 6. Kidney Cancer Diagnostic Services Features
Figure 7. Other Features
Figure 8. Global Tumor Diagnosis Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Tumor Diagnosis Solutions Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Tumor Diagnosis Solutions Report Years Considered
Figure 14. Global Tumor Diagnosis Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Tumor Diagnosis Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tumor Diagnosis Solutions Market Share by Region: 2024 VS 2031
Figure 17. Global Tumor Diagnosis Solutions Market Share by Players in 2024
Figure 18. Global Top Tumor Diagnosis Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Diagnosis Solutions as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Tumor Diagnosis Solutions Revenue in 2024
Figure 20. North America Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Tumor Diagnosis Solutions Market Share by Country (2020-2031)
Figure 22. United States Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Tumor Diagnosis Solutions Market Share by Country (2020-2031)
Figure 26. Germany Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Tumor Diagnosis Solutions Market Share by Region (2020-2031)
Figure 34. China Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Tumor Diagnosis Solutions Market Share by Country (2020-2031)
Figure 42. Mexico Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Tumor Diagnosis Solutions Market Share by Country (2020-2031)
Figure 46. Turkey Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Tumor Diagnosis Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Dian Diagnostics Group Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 50. Sansure Biotech Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 51. YHLO Biotech Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 53. Amoy Diagnostics Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 54. Ibex Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 55. Elephas Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 56. Philips Healthcare Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 57. Lepu Medical Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 58. Epredia Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 60. Caris Life Sciences Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 61. NeoGenomics Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 62. OncoDNA Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 63. Kheiron Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 64. Abbott Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 65. Mirada Medical Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 66. GuardantHealth Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 67. Labcorp Revenue Growth Rate in Tumor Diagnosis Solutions Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies